rs1077667

This is a regulatory region variant variant in the TNFSF14 gene.

GWAS Catalog Trait Associations (4)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

multiple sclerosis

Allele G
OR 1.15
p 8.0e-33
N 41,505
Large GWAS
multi-ancestry
Shigesi N et al. The phenotypic and genetic association between endometriosis and immunological diseases. Human Reproduction (oxford, England) 40(6):1195-1209 (2025)
Allele G
OR 0.06
p 7.0e-12
N 62,543
Large GWAS
European
Allele G
OR 1.16
p 2.0e-24
N 38,589
Large GWAS
European
Allele G
OR 1.16
p 9.0e-14
N 26,621
Large GWAS
European

monocyte percentage of leukocytes

Allele T
OR 0.03
p 5.0e-11
N 170,494
Large GWAS
European

granulocyte percentage of myeloid white cells

Allele T
OR 0.03
p 8.0e-10
N 169,545
Large GWAS
European

monocyte count

Verma A et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (new York, N.y.) 385(6706):eadj1182 (2024)
Allele C
OR 0.03
p 5.0e-13
N 296,975
Major Consortium StudyLarge GWAS
European

About TNFSF14

The protein encoded by this gene is a member of the tumor necrosis factor (TNF) ligand family. This protein is a ligand for TNFRSF14, which is a member of the tumor necrosis factor receptor superfamily, and which is also known as a herpesvirus entry mediator (HVEM). This protein may function as a costimulatory factor for the activation of lymphoid cells and as a deterrent to infection by herpesvirus. This protein has been shown to stimulate the proliferation of T cells, and trigger apoptosis of various tumor cells. This protein is also reported to prevent tumor necrosis factor alpha mediated apoptosis in primary hepatocyte. Two alternatively spliced transcript variant encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]

View all TNFSF14 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…